EPA 2026
Home
Scientific Programme
Industry Sessions
Live Sessions
Abstracts
E-posters
Sponsors and Exhibitors
Effects of Semaglutide on Body Weight in Clozapine-Treated Individuals with Schizophrenia and Obesity: A Randomized Controlled Trial
Mar 31, 2026
—
10:00 AM
-
10:08 AM
Club A
Oral Communication
Presenter
:
Dan Siskind (Australia)
Session Type
Oral Communication
O096
Effects of Semaglutide on Body Weight in Clozapine-Treated Individuals with Schizophrenia and Obesity: A Randomized Controlled Trial